CTI BIOPHARMA CORP Contracts & Agreements

Amendment No. 2 to Employment Agreement by and between Adam R. Craig and CTI BioPharma Corp (Filed With SEC on May 15, 2023)

Amendment No. 2 to Severance Agreement by and between James Fong and CTI BioPharma Corp (Filed With SEC on May 15, 2023)

Agreement and Plan of Merger, dated May 10, 2023, among CTI BioPharma Corp., Swedish Orphan Biovitrum AB (publ) and Cleopatra Acquisition Corp (Filed With SEC on May 10, 2023)

Description of Securities (Filed With SEC on March 6, 2023)

Amendment No 1. to the Asset Return and Termination Agreement, by and between Baxalta Incorporated and CTI BioPharma Corp., dated as of May 31, 2022 (Filed With SEC on August 8, 2022)

CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on June 3, 2022)

CTI BioPharma Corp. Amended and Restated 2007 Employee Stock Purchase Plan (Filed With SEC on June 3, 2022)

Description of Securities (Filed With SEC on March 31, 2022)

Second Amendment to Office Lease, dated December 6, 2021, by and between CTI BioPharma Corp. and Selig Holdings Company, LLC (Filed With SEC on March 31, 2022)

Offer Letter, by and between CTI BioPharma Corp. and James K. Fong, dated as of March 1, 2022 (Filed With SEC on March 4, 2022)

Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of January 6, 2015 (Filed With SEC on March 4, 2022)

Amendment to Severance Agreement, by and between CTI BioPharma Corp. and James K. Fong, dated as of March 1, 2022 (Filed With SEC on March 4, 2022)

Purchase and Sale Agreement, dated August 25, 2021, by and between CTI BioPharma Corp. and Drug Royalty III LP 2 (Filed With SEC on November 12, 2021)

CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on June 7, 2021)

CTI BioPharma Corp. Amended and Restated 2007 Employee Stock Purchase Plan (Filed With SEC on June 7, 2021)

CTI BioPharma Corp. Director Compensation Policy (Filed With SEC on May 6, 2021)

Underwriting Agreement by and among the Company and the Representatives, dated as of March 31, 2021 (Filed With SEC on April 6, 2021)

Description of Securities (Filed With SEC on March 17, 2021)

CTI BioPharma Corp. Stock Option Agreement (Inducement Form) (Filed With SEC on March 17, 2021)

Open Market Sale AgreementSM, dated as of January 15, 2021, by and between CTI BioPharma Corp. and Jefferies LLC (Filed With SEC on January 15, 2021)

CTI BioPharma Corp. 2017 Equity Incentive Plan Stock Option Agreement (Filed With SEC on November 10, 2020)

Description of Securities (Filed With SEC on March 13, 2020)

Director Compensation Policy (Filed With SEC on March 13, 2020)

Open Market Sale AgreementSM, dated as of November 15, 2019, between CTI BioPharma Corp. and Jefferies LLC (Filed With SEC on November 15, 2019)

CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 17, 2019)

Director Compensation Policy (Filed With SEC on May 2, 2019)

Form of Warrant to Purchase Common Stock, dated November 6, 2018, issued to consultant to the Registrant (Filed With SEC on March 13, 2019)

CTI BioPharma Corp. Executive Incentive Compensation Plan (Filed With SEC on March 13, 2019)

Termination and Transfer Agreement, dated as of February 25, 2019, by and among on the one hand, CTI BioPharma Corp. and CTI Life Sciences Limited, and, on the other hand, Les... (Filed With SEC on February 27, 2019)

Amendment to Employment Agreement, dated October 31, 2018, by and between Adam R. Craig and the Company (Filed With SEC on November 1, 2018)

Sales Agreement, dated as of November 1, 2018, between CTI BioPharma Corp. and Cowen and Company, LLC (Filed With SEC on November 1, 2018)

First Amendment to Loan and Security Agreement, dated May 17, 2018, by and between Silicon Valley Bank and CTI BioPharma Corp (Filed With SEC on August 3, 2018)

CTI BioPharma Corp. Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 21, 2018)

Form of Stock Option Agreement under the Amended and Restated 2017 Equity Incentive Plan (Filed With SEC on May 21, 2018)

Waiver Agreement, dated January 19, 2018, by and between Silicon Valley Bank and the Registrant (Filed With SEC on March 7, 2018)

Agreement and Plan of Merger, dated January 24, 2018, by and between CTI BioPharma Corp., a Washington corporation, and CTI BioPharma Corp., a Delaware corporation (Filed With SEC on January 24, 2018)

Form of Indemnification Agreement (Filed With SEC on January 24, 2018)

Sublease agreement between CTI BioPharma Corp. and Cascadian Therapeutics, Inc (Filed With SEC on December 5, 2017)

Warrant to Purchase Stock, dated November 28, 2017, by and between CTI BioPharma Corp. and Silicon Valley Bank (Filed With SEC on November 28, 2017)

Warrant to Purchase Stock, dated November 28, 2017, by and between CTI BioPharma Corp. and Life Science Loans II, LLC (Filed With SEC on November 28, 2017)

Loan and Security Agreement, dated November 28, 2017, by and between CTI BioPharma Corp. and Silicon Valley Bank (Filed With SEC on November 28, 2017)

Fifth Amendment to Loan and Security Agreement, dated August 4, 2017, by and among Hercules Technology Growth Capital, Inc. (and certain of its affiliates), CTI BioPharma Corp.... (Filed With SEC on November 7, 2017)

Fourth Amendment to Shareholder Rights Agreement, dated as of 22, 2017, between the Company and Computershare Trust Company, N.A., as Rights Agent (Filed With SEC on September 26, 2017)

Severance Agreement by and between CTI BioPharma Corp. and David Kirske, dated September 25, 2017 (Filed With SEC on September 26, 2017)

SEPARATION AND RELEASE AGREEMENT (Filed With SEC on August 22, 2017)

[CTI Letterhead] (Filed With SEC on August 4, 2017)

22,500 Shares CTI BioPharma Corp. Series N-3 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on June 9, 2017)

[Signature Page to Follow] (Filed With SEC on June 9, 2017)

CTI BIOPHARMA CORP. 2017 EQUITY INCENTIVE PLAN (Filed With SEC on May 16, 2017)

CTI BIOPHARMA CORP. DIRECTOR COMPENSATION POLICY Effective February 23, 2017 (Filed With SEC on May 3, 2017)

Amended and Restated Exclusive License and Collaboration Agreement (Filed With SEC on May 3, 2017)

SEPARATION AND RELEASE AGREEMENT (Filed With SEC on March 13, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on February 27, 2017)

ASSET RETURN AND TERMINATION AGREEMENT (Filed With SEC on October 24, 2016)

CTI BIOPHARMA CORP. (Filed With SEC on October 24, 2016)

CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on October 24, 2016)

SEPARATION AND RELEASE AGREEMENT (Filed With SEC on October 3, 2016)

[Shire Letterhead] (Filed With SEC on September 19, 2016)

CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN (As Amended March 2, 2016) (Filed With SEC on April 29, 2016)

AMENDMENT NO. 3 to EMPLOYMENT AGREEMENT (Filed With SEC on February 17, 2016)

SEVERANCE AGREEMENT (Filed With SEC on February 17, 2016)

CTI BIOPHARMA CORP. DIRECTOR COMPENSATION POLICY Effective January 1, 2016 (Filed With SEC on February 17, 2016)

[Remainder of page intentionally left blank] (Filed With SEC on February 17, 2016)

CTI BioPharma Corp. (Filed With SEC on February 17, 2016)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 11, 2015)

55,000 Shares CTI BioPharma Corp. Series N-2 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2015)

[Signature Page to Follow] (Filed With SEC on December 9, 2015)

THIRD AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on December 1, 2015)

CTI BIOPHARMA CORP. DIRECTOR COMPENSATION POLICY Effective July 27, 2015 (Filed With SEC on November 5, 2015)

CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on November 5, 2015)

CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (GLOBAL FORM) (Filed With SEC on November 5, 2015)

CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (GLOBAL FORM) (Filed With SEC on November 5, 2015)

CTI BIOPHARMA CORP. 2015 EQUITY INCENTIVE PLAN STOCK BONUS AWARD AGREEMENT (GLOBAL FORM) (Filed With SEC on November 5, 2015)

50,000 Shares CTI BioPharma Corp. Series N-1 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 30, 2015)

SUBSCRIPTION AGREEMENT (Filed With SEC on September 29, 2015)

FIRST AMENDMENT TO DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BY AND AMONG Cti biopharma corp., BAXALTA INCORPORATED BAXALTA US INC. AND BAXALTA GMBH DATED: June 8, 2015 (Filed With SEC on August 6, 2015)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of CTI Biopharma Corp. Dated as of June 9, 2015 (the Effective Date) (Filed With SEC on June 10, 2015)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 10, 2015)

AMENDMENT NO. 2 to EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2015)

SEVERANCE AGREEMENT (Filed With SEC on March 12, 2015)

CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on March 12, 2015)

CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (GLOBAL FORM) (Filed With SEC on March 12, 2015)

CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (GLOBAL FORM) (Filed With SEC on March 12, 2015)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 12, 2015)

DATED 24 OCTOBER 2014 CHROMA THERAPEUTICS LIMITED -and- CTI BIOPHARMACORP. ASSET PURCHASE AGREEMENT relating to the sale and purchase of certain assets from Chroma Therapeutics... (Filed With SEC on November 6, 2014)

DATED _24_October 2014 VERNALIS (R&D) LTD (1) and CTI BIOPHARMACORP. (2) Amended and restated exclusive licence agreement covering BB-76163 and certain Other Compounds for use in... (Filed With SEC on November 6, 2014)

CTI BIOPHARMA CORP. 2007 EQUITY INCENTIVE PLAN Effective as of June20, 2003 and amended and restated as of September 17, 2014 SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on October 31, 2014)

Exclusive License and Collaboration Agreement (Filed With SEC on October 31, 2014)

INDEMNITY AGREEMENT (Filed With SEC on June 2, 2014)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 29, 2014)

TERMINATION AGREEMENT (Filed With SEC on April 29, 2014)

AMENDMENT No. 4 TO WHOLESALE DISTRIBUTION AGREEMENT (Filed With SEC on April 29, 2014)

[Cell Therapeutics, Inc. Letterhead] (Filed With SEC on March 4, 2014)

DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BY AND AMONG CELLTHERAPEUTICS, INC., BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE CORPORATION AND BAXTER HEALTHCARESA DATED:... (Filed With SEC on March 4, 2014)

CELL THERAPEUTICS, INC. A Washington Corporation (Filed With SEC on November 15, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 15, 2013)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on October 30, 2013)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN STOCK AWARD AGREEMENT (Filed With SEC on October 30, 2013)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on October 30, 2013)

AMENDMENT No. 3 TOWHOLESALE DISTRIBUTION AGREEMENT (Filed With SEC on October 30, 2013)

CELL THERAPEUTICS, INC. A Washington Corporation (Filed With SEC on September 18, 2013)

FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 18, 2013)

AMENDMENT No. 1 TO WHOLESALE DISTRIBUTION AGREEMENT (Filed With SEC on July 31, 2013)

AMENDMENT No. 2 TO WHOLESALE DISTRIBUTION AGREEMENT (Filed With SEC on July 31, 2013)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN Effective as of June 20, 2003 and amended and restated as of April 4, 2013 SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on June 26, 2013)

AMENDMENT to EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2013)

[Cell Therapeutics, Inc. Letterhead] (Filed With SEC on May 2, 2013)

WHOLESALE DISTRIBUTION AGREEMENT (Filed With SEC on May 2, 2013)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of Cell Therapeutics, Inc. Dated as of March 26, 2013 (the Effective Date) (Filed With SEC on March 28, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 28, 2013)

SEVERANCE AGREEMENT (Filed With SEC on March 22, 2013)

[Cell Therapeutics, Inc. Letterhead] (Filed With SEC on February 28, 2013)

SEVERANCE AGREEMENT (Filed With SEC on February 28, 2013)

[Cell Therapeutics, Inc. Letterhead] (Filed With SEC on February 28, 2013)

SETTLEMENT AGREEMENT AND FULL AND FINAL RELEASE OF CLAIMS (Filed With SEC on February 28, 2013)

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE (Filed With SEC on December 31, 2012)

SECOND AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on December 7, 2012)

LOGISTICS AGREEMENT Dated September 1, 2012 (Filed With SEC on November 1, 2012)

SETTLEMENT AGREEMENT AND FULL AND FINAL RELEASE OF CLAIMS (Filed With SEC on October 31, 2012)

60,000 Shares Cell Therapeutics, Inc. Series 17 Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on October 11, 2012)

CELL THERAPEUTICS, INC. A Washington Corporation (Filed With SEC on October 11, 2012)

FIRST AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT (Filed With SEC on September 4, 2012)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN Effective as of June 20, 2003 and amended and restated as of July 16, 2012 (All share numbers in this document are presented... (Filed With SEC on September 4, 2012)

CELL THERAPEUTICS, INC. DIRECTOR COMPENSATION POLICY Effective June 27, 2012 (Filed With SEC on August 2, 2012)

MASTER SERVICES AGREEMENT BETWEEN QUINTILES COMMERCIAL EUROPE LIMITED AND CTI LIFE SCIENCES LIMITED (Filed With SEC on August 2, 2012)

Letter of Guarantee (Filed With SEC on August 2, 2012)

FORM OF WARRANT WARRANT TOPURCHASE COMMON STOCK (Filed With SEC on August 1, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 5, 2012)

ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF CELL THERAPEUTICS, INC. DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES 16 PREFERRED STOCK (Filed With SEC on June 5, 2012)

CELL THERAPEUTICS, INC. A Washington Corporation (Filed With SEC on May 31, 2012)

FORM OF WARRANT WARRANT TOPURCHASE COMMON STOCK (Filed With SEC on May 31, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 31, 2012)

ASSET PURCHASE AGREEMENT between S*BIOPTE LTD. and CELL THERAPEUTICS, INC. Dated as of April 18, 2012 Table of Contents (Filed With SEC on April 24, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 24, 2012)

ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF CELL THERAPEUTICS, INC. DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES [ ] PREFERRED STOCK (Filed With SEC on April 24, 2012)

[Cell Therapeutics, Inc. Letterhead] (Filed With SEC on April 20, 2012)

3101 WESTERN AVENUE OFFICE LEASE (Filed With SEC on March 8, 2012)

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE (Filed With SEC on February 15, 2012)

1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on December 14, 2011)

CELL THERAPEUTICS, INC. A Washington Corporation (Filed With SEC on December 14, 2011)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on December 14, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 14, 2011)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN Effective as of June 20, 2003 and amended and restated as of October 4, 2011 SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on November 15, 2011)

CELL THERAPEUTICS, INC. 501 Elliott Avenue West, Suite 400 Seattle, Washington 98119 (Filed With SEC on October 25, 2011)

CELL THERAPEUTICS, INC. REVISED DIRECTOR COMPENSATION POLICY Effective September 20, 2011 (Filed With SEC on September 26, 2011)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on July 28, 2011)

1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on July 6, 2011)

CELL THERAPEUTICS, INC. A Washington Corporation (Filed With SEC on July 6, 2011)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on July 6, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 6, 2011)

1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on May 2, 2011)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of CommonStock of CELL THERAPEUTICS, INC. (Filed With SEC on May 2, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 2, 2011)

CO-DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on April 26, 2011)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on April 26, 2011)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN DIRECTOR RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on April 26, 2011)

CELL THERAPEUTICS, INC. JAMES BIANCO EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2011)

COMMON STOCK PURCHASE WARRANT To Purchase 25,919,733 Shares ofCommon Stock of CELL THERAPEUTICS, INC. (Filed With SEC on February 24, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 24, 2011)

[Cell Therapeutics, Inc. Letterhead] (Filed With SEC on February 16, 2011)

COMMON STOCK PURCHASE WARRANT To Purchase 22,563,177 Shares ofCommon Stock of CELL THERAPEUTICS, INC. (Filed With SEC on January 18, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 18, 2011)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on October 28, 2010)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on October 22, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 22, 2010)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN Effective as of June 20, 2003 and amended and restated as of August 23, 2010 SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on September 17, 2010)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on August 6, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 6, 2010)

EXCHANGE AGREEMENT (Filed With SEC on August 6, 2010)

DRUG PRODUCT MANUFACTURING SUPPLY AGREEMENT (Filed With SEC on August 6, 2010)

1251 Avenue of the Americas,20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on May 27, 2010)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on May 27, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 27, 2010)

1251 Avenue of the Americas, 20th Floor, New York, NY10020 q Tel: 212 ###-###-#### Fax: 212 ###-###-#### (Filed With SEC on April 5, 2010)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on April 5, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 5, 2010)

CELL THERAPEUTICS, INC. REVISED DIRECTORCOMPENSATION POLICY Approved August 24, 2009 (Filed With SEC on February 26, 2010)

Opaxio NDA Approval (Filed With SEC on February 26, 2010)

EPS Goal (Filed With SEC on February 26, 2010)

1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on January 19, 2010)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on January 19, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 19, 2010)

INDEMNITY AGREEMENT (Filed With SEC on December 17, 2009)

COMMON STOCK PURCHASE WARRANT To Purchase 337,319Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on November 5, 2009)

CELL THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN (Filed With SEC on October 23, 2009)

CELL THERAPEUTICS, INC. 2007 Employee StockPurchase Plan (Filed With SEC on October 23, 2009)

1251 Avenue of theAmericas, 20th Floor, New York, NY 10020 Tel ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on August 21, 2009)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of CommonStock of CELL THERAPEUTICS, INC. (Filed With SEC on August 21, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 21, 2009)

SECOND AMENDMENT TO ACQUISITION AGREEMENT (Filed With SEC on August 7, 2009)

COMMON STOCK PURCHASE WARRANT To Purchase 1,000,000 Shares of Common Stock of (Filed With SEC on August 6, 2009)

COMMON STOCK PURCHASE WARRANT To Purchase 320,000 Shares of Common Stock of (Filed With SEC on August 6, 2009)

Underwriting Agreement (Filed With SEC on July 28, 2009)

COMMON STOCK PURCHASE WARRANT To Purchase [] Shares of CommonStock of CELL THERAPEUTICS, INC. (Filed With SEC on July 28, 2009)

Regione Lombardia PROCEDURE FOR THE DECLARATION OF MOBILITY (Filed With SEC on May 20, 2009)

FORM OF COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on May 12, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 12, 2009)

EXCHANGE AGREEMENT (Filed With SEC on April 17, 2009)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on April 13, 2009)

www.rodm.com Member: FINRA, SIPC (Filed With SEC on April 13, 2009)

CLASS A COMMON STOCK PURCHASE WARRANT To Purchase 9,183,562 Shares of Common Stock of (Filed With SEC on April 13, 2009)

CLASS B COMMON STOCK PURCHASE WARRANT To Purchase 13,316,438 Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on April 13, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 13, 2009)

FORM OF STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT (Filed With SEC on March 16, 2009)

[date] (Filed With SEC on March 16, 2009)

CELL THERAPEUTICS, INC. REVISED DIRECTOR COMPENSATION POLICY (Filed With SEC on March 16, 2009)

TERMINATION AGREEMENT (Filed With SEC on March 16, 2009)

FIRST AMENDMENT TO (Filed With SEC on March 16, 2009)

AMENDED AND RESTATED SECURITY AGREEMENT (Filed With SEC on March 16, 2009)

CELL THERAPEUTICS, INC. JAMES BIANCO EMPLOYMENT AGREEMENT (Filed With SEC on January 6, 2009)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on December 8, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 8, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on October 24, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 24, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on October 1, 2008)

AMENDMENT OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 1, 2008)

SECOND AMENDMENT OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 1, 2008)

RELEASE (Filed With SEC on October 1, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on September 17, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 17, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on August 20, 2008)

ACCESS AGREEMENT (Filed With SEC on August 18, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on August 18, 2008)

ATTACHMENT A TO CONSULTING LETTER AGREEMENT DESCRIPTION OF SERVICES (Filed With SEC on August 18, 2008)

AMENDMENT AGREEMENT (Filed With SEC on August 6, 2008)

COMMON STOCK PURCHASE WARRANT To Purchase up to $12,000,000 in Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on July 30, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 30, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on July 25, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on June 13, 2008)

AMENDMENT OF SECURITIES PURCHASE AGREEMENT AND SERIES B UNIT PURCHASE WARRANT (Filed With SEC on June 13, 2008)

SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on May 12, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on May 2, 2008)

SERIES A COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on May 2, 2008)

SERIES B UNIT PURCHASE WARRANT To Purchase Units Consisting of 12.50% Series B Convertible Notes and Series A Common Stock Purchase Warrants of CELL THERAPEUTICS, INC. (Filed With SEC on May 2, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 2, 2008)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on March 5, 2008)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on March 5, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 5, 2008)

FORM OF EXCHANGE AGREEMENT (Filed With SEC on February 19, 2008)

SECURITY AGREEMENT (Filed With SEC on December 31, 2007)

CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIALTREATMENT HAS BEEN REQUESTED IS OMITTED AND IS NOTED WITH [CONFIDENTIAL TREATMENT REQUESTED]. AN UNREDACTED... (Filed With SEC on December 31, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELLTHERAPEUTICS, INC. (Filed With SEC on December 27, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 27, 2007)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on December 13, 2007)

CELL THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 13, 2007)

FORM OF EXCHANGE AGREEMENT (Filed With SEC on December 13, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELLTHERAPEUTICS, INC. (Filed With SEC on December 3, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 3, 2007)

ASSET PURCHASE AGREEMENT (Filed With SEC on August 21, 2007)

ACQUISITION AGREEMENT AMONG (Filed With SEC on July 27, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELLTHERAPEUTICS, INC. (Filed With SEC on July 27, 2007)

FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 27, 2007)

CELL THERAPEUTICS, INC. DIRECTOR COMPENSATION POLICY (Filed With SEC on April 27, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on April 16, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 16, 2007)

THIRD AMENDMENT TO SUBLEASE AGREEMENT (Filed With SEC on March 16, 2007)

Modified Compensation Arrangement for Non-Employee Directors (Filed With SEC on March 16, 2007)

Amendment to the Modified Compensation Arrangement for Non-Employee Directors (Filed With SEC on March 16, 2007)

Authorization of Bonus and Contingent Bonus Payment. (Filed With SEC on March 16, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 14, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of CELL THERAPEUTICS, INC. (Filed With SEC on February 12, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 12, 2007)

AMENDMENT NO. 3 TO THE STEP-UP EQUITY FINANCING AGREEMENT (Filed With SEC on December 21, 2006)

AGREEMENT (Filed With SEC on October 19, 2006)

WARRANT REPURCHASE AGREEMENT (Filed With SEC on October 19, 2006)

AMENDMENT NO. 2 TO THE STEP-UP EQUITY FINANCING AGREEMENT (Filed With SEC on October 5, 2006)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 20, 2006)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 18, 2006)

License and Co-Development Agreement By and Between (Filed With SEC on September 18, 2006)

NOVARTIS PHARMA AG AND CELL THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT TABLE OF CONTENTS (Filed With SEC on September 18, 2006)

AMENDMENT NO. 1 TO THE STEP-UP EQUITY FINANCING AGREEMENT (Filed With SEC on August 3, 2006)

STEP-UP EQUITY FINANCING AGREEMENT Dated June 21, 2006 (Filed With SEC on June 23, 2006)

CELL THERAPEUTICS, INC., as Company U.S. BANK NATIONAL ASSOCIATION, as Trustee (Filed With SEC on April 28, 2006)

CELL THERAPEUTICS, INC. 7.5% CONVERTIBLE SENIOR NOTES DUE 2011 (Filed With SEC on April 28, 2006)

Cell Therapeutics, Inc. $33,156,000 7.5% Convertible Senior Notes due 2011 PURCHASE AGREEMENT (Filed With SEC on April 28, 2006)

EXCHANGE AGREEMENT by and among CELL THERAPEUTICS, INC., and (Filed With SEC on April 28, 2006)

AMENDMENT NO. 1 (Filed With SEC on February 7, 2006)

CELL THERAPEUTICS, INC., asCompany U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of November 4, 2005 6.75%CONVERTIBLE SENIOR NOTES DUE 2010 TABLE OF CONTENTS (Filed With SEC on November 10, 2005)

CELL THERAPEUTICS, INC. (Filed With SEC on November 10, 2005)

CELL THERAPEUTICS, INC., and LINDEN CAPITAL L.P. and (Filed With SEC on November 3, 2005)

SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on June 29, 2005)

CELL THERAPEUTICS, INC., CTI TECHNOLOGIES, INC. (Filed With SEC on June 14, 2005)

FORM OF STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT (Filed With SEC on April 18, 2005)

APPENDIX A (Filed With SEC on March 4, 2005)

Shares (Filed With SEC on March 4, 2005)

[FORM OF STANDARD NONQUALIFIED STOCK OPTION AGREEMENT] CELL THERAPEUTICS, INC. NOVUSPHARMA S.p.A. STOCK OPTION PLAN NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 4, 2005)

[CONFIDENTIAL TREATMENT REQUESTED] FINANCING AGREEMENT (Filed With SEC on March 4, 2005)

CELL THERAPEUTICS, INC. (Filed With SEC on January 6, 2005)

[CONFIDENTIAL TREATMENT REQUESTED] FINANCING AGREEMENT (Filed With SEC on December 23, 2004)

GUARANTY AGREEMENT (Filed With SEC on December 23, 2004)

SECURITY AGREEMENT (Filed With SEC on December 23, 2004)

CELL THERAPEUTICS, INC. (Filed With SEC on December 23, 2004)

STRATEGIC MANAGEMENT TEAM SEVERANCE AGREEMENT (Filed With SEC on October 4, 2004)

UNDERWRITING AGREEMENT (Filed With SEC on August 6, 2004)

CELL THERAPEUTICS, INC., asIssuer U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 23, 2003 4% CONVERTIBLESENIOR SUBORDINATED NOTES DUE 2010 TABLE OF CONTENTS (Filed With SEC on August 6, 2003)

Cell Therapeutics, Inc. (Filed With SEC on August 6, 2003)

CELL THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on July 9, 2003)

CELL THERAPEUTICS, INC. (Filed With SEC on July 9, 2003)

CELL THERAPEUTICS, INC. AND NOVUSPHARMA,S.p.A. DATED (Filed With SEC on June 17, 2003)

FORM OF NOVUSPHARMA SHAREHOLDER VOTING AGREEMENT (Filed With SEC on June 17, 2003)

FORM OF CTI STOCKHOLDER VOTING AGREEMENT (Filed With SEC on June 17, 2003)

CTI STOCKHOLDER VOTING AGREEMENT (Filed With SEC on June 17, 2003)

[CONFIDENTIAL TREATMENT REQUESTED.CONFIDENTIAL PORTIONS OF THIS DOCUMENTS HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.] SPONSOREDRESEARCH AGREEMENT (Filed With SEC on November 14, 2002)

Category

Industry

Companies

Contracts

CTI BIOPHARMA CORP Contracts & Agreements